SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-121227
Filing Date
2021-04-19
Accepted
2021-04-19 16:05:55
Documents
15
Period of Report
2021-04-15
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d31123d8k.htm   iXBRL 8-K 29661
2 EX-99.1 d31123dex991.htm EX-99.1 11280
3 EX-99.2 d31123dex992.htm EX-99.2 10673
7 GRAPHIC g31123g0419065519842.jpg GRAPHIC 2692
  Complete submission text file 0001193125-21-121227.txt   186221

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA zyme-20210415.xsd EX-101.SCH 2728
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE zyme-20210415_lab.xml EX-101.LAB 18082
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE zyme-20210415_pre.xml EX-101.PRE 11368
8 EXTRACTED XBRL INSTANCE DOCUMENT d31123d8k_htm.xml XML 3450
Mailing Address 540-1385 WEST 8TH AVENUE Vancouver A1 V6H 3V9
Business Address 540-1385 WEST 8TH AVENUE Vancouver A1 V6H 3V9 (604) 678-1388
Zymeworks Inc. (Filer) CIK: 0001403752 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38068 | Film No.: 21834626
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences